ID: ALA5278682

Max Phase: Preclinical

Molecular Formula: C18H13N3O3

Molecular Weight: 319.32

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=c2\c(=O)[nH]n3c(=O)c4ccccc4nc23)cc1

Standard InChI:  InChI=1S/C18H13N3O3/c1-24-12-8-6-11(7-9-12)10-14-16-19-15-5-3-2-4-13(15)18(23)21(16)20-17(14)22/h2-10H,1H3,(H,20,22)/b14-10-

Standard InChI Key:  QNBMVIAVMRUVAY-UVTDQMKNSA-N

Associated Targets(Human)

PTGS2 Tclin COX-1/COX-2 (288 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.32Molecular Weight (Monoisotopic): 319.0957AlogP: 1.09#Rotatable Bonds: 2
Polar Surface Area: 76.46Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.64CX Basic pKa: 2.98CX LogP: 2.20CX LogD: 2.03
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.60Np Likeness Score: -0.70

References

1. Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K..  (2022)  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.,  13  (5.0): [PMID:35685617] [10.1039/d1md00280e]

Source